An experimental new cancer drug has proven beneficial for a handful of individuals. If all goes to plan, it will be available ...

CStone Pharmaceuticals (HK:2616) has released an update. CStone Pharmaceuticals has unveiled promising preclinical data for ...

The CSHL study underscores the value of interdisciplinary research in making breakthrough discoveries. By bringing together ...

Omega fatty acids have emerged as a key focus in recent groundbreaking research, revealing remarkable insights into how these ...

A new drug combination could help breast cancer sufferers live up to twice as long without the disease progressing, according ...

Paul Read, a 62-year-old engineer, was the first patient to undergo an experimental trial where radiation is injected ...

Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving the way for future treatments.

Dr Tina Willits was given just 24 months to live after a cancer diagnosis. Against all odds, she's now in remission.

Researchers say the therapy is potentially transformative for those with a common form of advanced, aggressive breast cancer ...

Researchers hope identification of new RNA molecules will help doctors predict if a patient’s bowel cancer will return or not.

The therapy involved injecting low levels of radioactivity directly into the tumour to eliminate cancer cells.

In addition, Imugene has made strides in expanding its trial. The Cohort Review Committee has cleared the first cohort of ...